James Brady
Director/Board Member at VERONA PHARMA PLC
Net worth: - $ as of 30/04/2024
Profile
James Brady is an Independent Non-Executive Director at Verona Pharma Plc and a Director at Panavance Therapeutics, Inc. He was previously the Chief Financial Officer at MedImmune Ltd.
from 2013 to 2018.
He holds an MBA from Drexel University and an undergraduate degree from St. Joseph University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERONA PHARMA PLC
-.--% | 29/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
James Brady active positions
| Companies | Position | Start |
|---|---|---|
| VERONA PHARMA PLC | Director/Board Member | 14/03/2022 |
| Panavance Therapeutics, Inc. | Director/Board Member | - |
Former positions of James Brady
| Companies | Position | End |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Director of Finance/CFO | 01/01/2018 |
Training of James Brady
| Drexel University | Masters Business Admin |
| St. Joseph University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Private companies | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Panavance Therapeutics, Inc. |
- Stock Market
- Insiders
- James Brady